R Dirk Allison Sells 25,000 Shares of Addus HomeCare Co. (NASDAQ:ADUS) Stock

Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

R Dirk Allison also recently made the following trade(s):

• On Monday, November 25th, R Dirk Allison sold 12,500 shares of Addus HomeCare stock. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00.

Addus HomeCare Trading Up 0.3 %

Addus HomeCare stock opened at $124.59 on Friday. Addus HomeCare Co. has a 12-month low of $85.94 and a 12-month high of $136.12. The firm has a market capitalization of $2.26 billion, a price-to-earnings ratio of 28.51, a P/E/G ratio of 2.11 and a beta of 1.00. The firm has a 50 day moving average of $125.12 and a 200 day moving average of $125.79.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the firm earned $1.03 EPS. On average, analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Addus HomeCare during the third quarter worth about $1,622,000. Dimensional Fund Advisors LP boosted its stake in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the period. Point72 Asset Management L.P. grew its holdings in Addus HomeCare by 73.4% during the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after buying an additional 315,602 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Addus HomeCare by 136.5% during the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company’s stock valued at $9,294,000 after buying an additional 46,199 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of Addus HomeCare by 90.6% in the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after buying an additional 8,743 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. JMP Securities assumed coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Stephens boosted their price target on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare currently has a consensus rating of “Buy” and a consensus price target of $133.67.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.